7:57 AM ET
8-K
Leadership Change
Akebia Therapeutics Leadership Change
Nicholas Grund, Senior Vice President and Chief Commercial Officer, notified Akebia Therapeutics of his resignation effective November 6, 2026, for personal reasons. Following his departure, Mr. Grund will provide consulting and advisory services to the company through April 30, 2027, under a newly established consulting agreement.
- Term
- through April 30, 2027